nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Crohn's disease—Behcet's disease	0.291	0.315	CtDrD
Sulfasalazine—ankylosing spondylitis—Behcet's disease	0.224	0.243	CtDrD
Sulfasalazine—ulcerative colitis—Behcet's disease	0.206	0.223	CtDrD
Sulfasalazine—rheumatoid arthritis—Behcet's disease	0.202	0.219	CtDrD
Sulfasalazine—PLA2G1B—blood vessel—Behcet's disease	0.00242	0.0538	CbGeAlD
Sulfasalazine—PLA2G1B—mouth—Behcet's disease	0.00203	0.045	CbGeAlD
Sulfasalazine—SLC7A11—mouth—Behcet's disease	0.00178	0.0394	CbGeAlD
Sulfasalazine—ACAT1—Tryptophan metabolism—CAT—Behcet's disease	0.00149	0.0478	CbGpPWpGaD
Sulfasalazine—PPARG—artery—Behcet's disease	0.0014	0.0311	CbGeAlD
Sulfasalazine—ACAT1—cardiac atrium—Behcet's disease	0.0014	0.031	CbGeAlD
Sulfasalazine—SLC46A1—eye—Behcet's disease	0.00137	0.0304	CbGeAlD
Sulfasalazine—ACAT1—medulla oblongata—Behcet's disease	0.00132	0.0293	CbGeAlD
Sulfasalazine—ACAT1—midbrain—Behcet's disease	0.00121	0.0267	CbGeAlD
Sulfasalazine—CHUK—skin of body—Behcet's disease	0.00119	0.0265	CbGeAlD
Sulfasalazine—PPARG—endothelium—Behcet's disease	0.00118	0.0262	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—Behcet's disease	0.00118	0.0261	CbGeAlD
Sulfasalazine—CHUK—NOD pathway—MEFV—Behcet's disease	0.0011	0.0354	CbGpPWpGaD
Sulfasalazine—PPARG—blood vessel—Behcet's disease	0.00109	0.0242	CbGeAlD
Sulfasalazine—IKBKB—NOD pathway—MEFV—Behcet's disease	0.001	0.0321	CbGpPWpGaD
Sulfasalazine—ACAT1—nervous system—Behcet's disease	0.000991	0.022	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—Behcet's disease	0.000954	0.0212	CbGeAlD
Sulfasalazine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—Behcet's disease	0.000943	0.0302	CbGpPWpGaD
Sulfasalazine—SLC46A1—spinal cord—Behcet's disease	0.000876	0.0194	CbGeAlD
Sulfasalazine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—MEFV—Behcet's disease	0.000855	0.0274	CbGpPWpGaD
Sulfasalazine—TBXAS1—nervous system—Behcet's disease	0.000829	0.0184	CbGeAlD
Sulfasalazine—IKBKB—skin of body—Behcet's disease	0.000811	0.018	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—Behcet's disease	0.000798	0.0177	CbGeAlD
Sulfasalazine—SLC7A11—Cell surface interactions at the vascular wall—ITGB2—Behcet's disease	0.000772	0.0247	CbGpPWpGaD
Sulfasalazine—ACAT1—brain—Behcet's disease	0.000758	0.0168	CbGeAlD
Sulfasalazine—PTGS1—artery—Behcet's disease	0.000748	0.0166	CbGeAlD
Sulfasalazine—IKBKB—mammalian vulva—Behcet's disease	0.00074	0.0164	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—CAT—Behcet's disease	0.00074	0.0237	CbGpPWpGaD
Sulfasalazine—SLC7A11—midbrain—Behcet's disease	0.00074	0.0164	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—Behcet's disease	0.000738	0.0164	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—Behcet's disease	0.000722	0.016	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—APOB—Behcet's disease	0.000718	0.023	CbGpPWpGaD
Sulfasalazine—PTGS2—artery—Behcet's disease	0.000715	0.0159	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—Behcet's disease	0.000711	0.0158	CbGeAlD
Sulfasalazine—SLC7A11—Cell surface interactions at the vascular wall—ITGAL—Behcet's disease	0.000696	0.0223	CbGpPWpGaD
Sulfasalazine—PLA2G1B—nervous system—Behcet's disease	0.000694	0.0154	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—Behcet's disease	0.000668	0.0148	CbGeAlD
Sulfasalazine—TBXAS1—brain—Behcet's disease	0.000633	0.0141	CbGeAlD
Sulfasalazine—PTGS1—endothelium—Behcet's disease	0.000632	0.014	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—Behcet's disease	0.000608	0.0135	CbGeAlD
Sulfasalazine—PTGS2—endothelium—Behcet's disease	0.000604	0.0134	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—Behcet's disease	0.000585	0.013	CbGeAlD
Sulfasalazine—PTGS1—blood vessel—Behcet's disease	0.000583	0.0129	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—APOA1—Behcet's disease	0.000568	0.0182	CbGpPWpGaD
Sulfasalazine—CHUK—brain—Behcet's disease	0.000564	0.0125	CbGeAlD
Sulfasalazine—SLC46A1—brain—Behcet's disease	0.000564	0.0125	CbGeAlD
Sulfasalazine—PTGS2—blood vessel—Behcet's disease	0.000557	0.0124	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—ICAM1—Behcet's disease	0.00054	0.0173	CbGpPWpGaD
Sulfasalazine—PLA2G1B—brain—Behcet's disease	0.000531	0.0118	CbGeAlD
Sulfasalazine—PPARG—skin of body—Behcet's disease	0.000505	0.0112	CbGeAlD
Sulfasalazine—IKBKB—nervous system—Behcet's disease	0.000502	0.0111	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—Behcet's disease	0.000483	0.0107	CbGeAlD
Sulfasalazine—PTGS2—mouth—Behcet's disease	0.000466	0.0103	CbGeAlD
Sulfasalazine—SLC7A11—brain—Behcet's disease	0.000465	0.0103	CbGeAlD
Sulfasalazine—PPARG—mammalian vulva—Behcet's disease	0.00046	0.0102	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—SERPINE1—Behcet's disease	0.000451	0.0145	CbGpPWpGaD
Sulfasalazine—ALOX5—nervous system—Behcet's disease	0.000416	0.00923	CbGeAlD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.000411	0.0132	CbGpPWpGaD
Sulfasalazine—ALOX5—central nervous system—Behcet's disease	0.000401	0.00889	CbGeAlD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—ITGB2—Behcet's disease	0.000387	0.0124	CbGpPWpGaD
Sulfasalazine—ACAT1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	0.000385	0.0123	CbGpPWpGaD
Sulfasalazine—IKBKB—brain—Behcet's disease	0.000384	0.00851	CbGeAlD
Sulfasalazine—SLC7A11—Cell surface interactions at the vascular wall—APOB—Behcet's disease	0.000383	0.0123	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—CAT—Behcet's disease	0.000348	0.0112	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—APOB—Behcet's disease	0.000338	0.0108	CbGpPWpGaD
Sulfasalazine—CHUK—FoxO family signaling—CAT—Behcet's disease	0.000323	0.0104	CbGpPWpGaD
Sulfasalazine—ALOX5—brain—Behcet's disease	0.000318	0.00706	CbGeAlD
Sulfasalazine—PPARG—nervous system—Behcet's disease	0.000312	0.00693	CbGeAlD
Sulfasalazine—CHUK—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000305	0.00979	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.000304	0.00976	CbGpPWpGaD
Sulfasalazine—PPARG—central nervous system—Behcet's disease	0.000301	0.00667	CbGeAlD
Sulfasalazine—ABCG2—mammalian vulva—Behcet's disease	0.000295	0.00655	CbGeAlD
Sulfasalazine—IKBKB—FoxO family signaling—CAT—Behcet's disease	0.000293	0.00939	CbGpPWpGaD
Sulfasalazine—ABCC2—ABC-family proteins mediated transport—APOA1—Behcet's disease	0.000283	0.00909	CbGpPWpGaD
Sulfasalazine—IKBKB—EBV LMP1 signaling—CXCL8—Behcet's disease	0.000277	0.00888	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—ITGB2—Behcet's disease	0.000276	0.00885	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.000271	0.00869	CbGpPWpGaD
Sulfasalazine—PTGS1—skin of body—Behcet's disease	0.00027	0.00599	CbGeAlD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000267	0.00857	CbGpPWpGaD
Sulfasalazine—ABCG2—medulla oblongata—Behcet's disease	0.000266	0.00591	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—TNF—Behcet's disease	0.000266	0.00853	CbGpPWpGaD
Sulfasalazine—PTGS1—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000265	0.00851	CbGpPWpGaD
Sulfasalazine—PTGS2—skin of body—Behcet's disease	0.000258	0.00572	CbGeAlD
Sulfasalazine—CHUK—Interleukin-11 Signaling Pathway—ICAM1—Behcet's disease	0.000257	0.00823	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.000254	0.00814	CbGpPWpGaD
Sulfasalazine—PTGS1—mammalian vulva—Behcet's disease	0.000246	0.00546	CbGeAlD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—ITGB2—Behcet's disease	0.000246	0.00788	CbGpPWpGaD
Sulfasalazine—ABCG2—midbrain—Behcet's disease	0.000244	0.0054	CbGeAlD
Sulfasalazine—PPARG—brain—Behcet's disease	0.000239	0.0053	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—Behcet's disease	0.000238	0.00527	CbGeAlD
Sulfasalazine—PTGS1—cardiac atrium—Behcet's disease	0.000236	0.00523	CbGeAlD
Sulfasalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—Behcet's disease	0.000235	0.00752	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-11 Signaling Pathway—ICAM1—Behcet's disease	0.000233	0.00747	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—Behcet's disease	0.000229	0.00733	CbGpPWpGaD
Sulfasalazine—CHUK—RANKL/RANK Signaling Pathway—ICAM1—Behcet's disease	0.000215	0.00689	CbGpPWpGaD
Sulfasalazine—CHUK—EBV LMP1 signaling—TNF—Behcet's disease	0.000213	0.00681	CbGpPWpGaD
Sulfasalazine—CHUK—Canonical NF-kappaB pathway—TNF—Behcet's disease	0.000213	0.00681	CbGpPWpGaD
Sulfasalazine—PTGS2—medulla oblongata—Behcet's disease	0.000212	0.00471	CbGeAlD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000212	0.0068	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—CXCL8—Behcet's disease	0.000211	0.00676	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—ITGB2—Behcet's disease	0.000209	0.00671	CbGpPWpGaD
Sulfasalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—Behcet's disease	0.000205	0.00658	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-2-alpha transcription factor network—SERPINE1—Behcet's disease	0.000205	0.00657	CbGpPWpGaD
Sulfasalazine—IKBKB—Type II diabetes mellitus—TNF—Behcet's disease	0.0002	0.0064	CbGpPWpGaD
Sulfasalazine—PTGS1—spinal cord—Behcet's disease	0.000198	0.0044	CbGeAlD
Sulfasalazine—IKBKB—RANKL/RANK Signaling Pathway—ICAM1—Behcet's disease	0.000195	0.00625	CbGpPWpGaD
Sulfasalazine—PTGS2—midbrain—Behcet's disease	0.000194	0.00431	CbGeAlD
Sulfasalazine—ACAT1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000194	0.00621	CbGpPWpGaD
Sulfasalazine—IKBKB—EBV LMP1 signaling—TNF—Behcet's disease	0.000193	0.00618	CbGpPWpGaD
Sulfasalazine—IKBKB—Canonical NF-kappaB pathway—TNF—Behcet's disease	0.000193	0.00618	CbGpPWpGaD
Sulfasalazine—PTGS2—spinal cord—Behcet's disease	0.000189	0.0042	CbGeAlD
Sulfasalazine—SLC7A11—Hemostasis—ITGAL—Behcet's disease	0.000189	0.00605	CbGpPWpGaD
Sulfasalazine—PTGS1—Overview of nanoparticle effects—TNF—Behcet's disease	0.000185	0.00592	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	0.000175	0.0056	CbGpPWpGaD
Sulfasalazine—PTGS1—nervous system—Behcet's disease	0.000167	0.0037	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—Behcet's disease	0.000161	0.00357	CbGeAlD
Sulfasalazine—PTGS2—nervous system—Behcet's disease	0.00016	0.00354	CbGeAlD
Sulfasalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—Behcet's disease	0.000159	0.0051	CbGpPWpGaD
Sulfasalazine—PTGS2—central nervous system—Behcet's disease	0.000154	0.00341	CbGeAlD
Sulfasalazine—ACAT1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000153	0.00491	CbGpPWpGaD
Sulfasalazine—ABCG2—brain—Behcet's disease	0.000153	0.0034	CbGeAlD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—CAT—Behcet's disease	0.000151	0.00484	CbGpPWpGaD
Sulfasalazine—CHUK—AGE/RAGE pathway—NOS3—Behcet's disease	0.000148	0.00475	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—TNF—Behcet's disease	0.000147	0.0047	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000147	0.0047	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—APOB—Behcet's disease	0.000146	0.00469	CbGpPWpGaD
Sulfasalazine—PPARG—PPARA activates gene expression—APOA1—Behcet's disease	0.000138	0.00444	CbGpPWpGaD
Sulfasalazine—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.000135	0.00434	CbGpPWpGaD
Sulfasalazine—IKBKB—AGE/RAGE pathway—NOS3—Behcet's disease	0.000134	0.00431	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—NOS3—Behcet's disease	0.000134	0.00429	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MEFV—Behcet's disease	0.000133	0.00427	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—TNF—Behcet's disease	0.000131	0.00421	CbGpPWpGaD
Sulfasalazine—PTGS1—brain—Behcet's disease	0.000128	0.00283	CbGeAlD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—TNF—Behcet's disease	0.000125	0.00401	CbGpPWpGaD
Sulfasalazine—CHUK—TNF receptor signaling pathway —TNF—Behcet's disease	0.000122	0.00391	CbGpPWpGaD
Sulfasalazine—PTGS2—brain—Behcet's disease	0.000122	0.00271	CbGeAlD
Sulfasalazine—SLC46A1—Transmembrane transport of small molecules—APOB—Behcet's disease	0.000122	0.00391	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	0.000122	0.0039	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—NOS3—Behcet's disease	0.000121	0.00389	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MEFV—Behcet's disease	0.000121	0.00387	CbGpPWpGaD
Sulfasalazine—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—Behcet's disease	0.00012	0.00386	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—CAT—Behcet's disease	0.00012	0.00384	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—TNF—Behcet's disease	0.000119	0.00382	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—APOB—Behcet's disease	0.000116	0.00373	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000116	0.00372	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—APOA1—Behcet's disease	0.000116	0.00371	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ERAP1—Behcet's disease	0.000114	0.00366	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —TNF—Behcet's disease	0.000111	0.00355	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.00011	0.00353	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000107	0.00343	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—TNF—Behcet's disease	0.000106	0.00339	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—APOB—Behcet's disease	0.000104	0.00333	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-B—Behcet's disease	0.000104	0.00333	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ERAP1—Behcet's disease	0.000103	0.00332	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Behcet's disease	9.72e-05	0.00312	CbGpPWpGaD
Sulfasalazine—SLC46A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	9.64e-05	0.00309	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—SERPINE1—Behcet's disease	9.61e-05	0.00308	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—TNF—Behcet's disease	9.59e-05	0.00308	CbGpPWpGaD
Sulfasalazine—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	9.33e-05	0.00299	CbGpPWpGaD
Sulfasalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—Behcet's disease	9.29e-05	0.00298	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	9.27e-05	0.00297	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—APOA1—Behcet's disease	9.2e-05	0.00295	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—SERPINE1—Behcet's disease	9.2e-05	0.00295	CbGpPWpGaD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—APOB—Behcet's disease	8.99e-05	0.00288	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—CAT—Behcet's disease	8.88e-05	0.00285	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ITGB2—Behcet's disease	8.78e-05	0.00282	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—ICAM1—Behcet's disease	8.74e-05	0.0028	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—APOB—Behcet's disease	8.62e-05	0.00276	CbGpPWpGaD
Sulfasalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—Behcet's disease	8.61e-05	0.00276	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	8.47e-05	0.00271	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ITGB2—Behcet's disease	8.43e-05	0.0027	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—CXCL8—Behcet's disease	8.41e-05	0.0027	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—APOA1—Behcet's disease	8.21e-05	0.00263	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ITGB2—Behcet's disease	7.96e-05	0.00255	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MEFV—Behcet's disease	7.76e-05	0.00249	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ITGB2—Behcet's disease	7.65e-05	0.00245	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ITGAL—Behcet's disease	7.61e-05	0.00244	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	7.58e-05	0.00243	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	7.54e-05	0.00242	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TNF—Behcet's disease	7.54e-05	0.00242	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—SERPINE1—Behcet's disease	7.3e-05	0.00234	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	7.24e-05	0.00232	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	7.23e-05	0.00232	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	7.19e-05	0.00231	CbGpPWpGaD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—APOA1—Behcet's disease	7.11e-05	0.00228	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MEFV—Behcet's disease	7.04e-05	0.00226	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—TNF—Behcet's disease	7.01e-05	0.00225	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ERAP1—Behcet's disease	6.92e-05	0.00222	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—ICAM1—Behcet's disease	6.91e-05	0.00222	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ITGAL—Behcet's disease	6.9e-05	0.00221	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TNF—Behcet's disease	6.84e-05	0.00219	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—Behcet's disease	6.84e-05	0.00219	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—APOA1—Behcet's disease	6.82e-05	0.00219	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—APOB—Behcet's disease	6.82e-05	0.00219	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—SERPINE1—Behcet's disease	6.78e-05	0.00217	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—Behcet's disease	6.76e-05	0.00217	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—CAT—Behcet's disease	6.73e-05	0.00216	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—CXCL8—Behcet's disease	6.56e-05	0.0021	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—APOB—Behcet's disease	6.53e-05	0.00209	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	6.52e-05	0.00209	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—SERPINE1—Behcet's disease	6.52e-05	0.00209	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	6.46e-05	0.00207	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—TNF—Behcet's disease	6.36e-05	0.00204	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERAP1—Behcet's disease	6.27e-05	0.00201	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—NOS3—Behcet's disease	6.23e-05	0.002	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	6e-05	0.00192	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—CAT—Behcet's disease	5.88e-05	0.00189	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—Behcet's disease	5.85e-05	0.00188	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	5.84e-05	0.00187	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—APOB—Behcet's disease	5.71e-05	0.00183	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—TNF—Behcet's disease	5.66e-05	0.00182	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—TNF—Behcet's disease	5.42e-05	0.00174	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—APOA1—Behcet's disease	5.39e-05	0.00173	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	5.3e-05	0.0017	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CTLA4—Behcet's disease	5.24e-05	0.00168	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—NOS3—Behcet's disease	5.17e-05	0.00166	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—APOA1—Behcet's disease	5.17e-05	0.00166	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ITGB2—Behcet's disease	5.12e-05	0.00164	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	5.04e-05	0.00162	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—CAT—Behcet's disease	4.91e-05	0.00157	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CXCL8—Behcet's disease	4.89e-05	0.00157	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—APOB—Behcet's disease	4.77e-05	0.00153	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CTLA4—Behcet's disease	4.75e-05	0.00152	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	4.7e-05	0.00151	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ITGB2—Behcet's disease	4.64e-05	0.00149	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ITGAL—Behcet's disease	4.61e-05	0.00148	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—Behcet's disease	4.57e-05	0.00147	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—APOA1—Behcet's disease	4.52e-05	0.00145	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—TNF—Behcet's disease	4.3e-05	0.00138	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—SERPINE1—Behcet's disease	4.28e-05	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ITGAL—Behcet's disease	4.18e-05	0.00134	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NOS3—Behcet's disease	4.09e-05	0.00131	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-B—Behcet's disease	4.03e-05	0.00129	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TNF—Behcet's disease	3.93e-05	0.00126	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—NOS3—Behcet's disease	3.92e-05	0.00126	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	3.91e-05	0.00125	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-B—Behcet's disease	3.87e-05	0.00124	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—APOA1—Behcet's disease	3.77e-05	0.00121	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—APOB—Behcet's disease	3.74e-05	0.0012	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	3.71e-05	0.00119	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.7e-05	0.00119	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-B—Behcet's disease	3.66e-05	0.00117	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—APOB—Behcet's disease	3.52e-05	0.00113	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-B—Behcet's disease	3.51e-05	0.00113	CbGpPWpGaD
Sulfasalazine—PPARG—Generic Transcription Pathway—SERPINE1—Behcet's disease	3.51e-05	0.00112	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CAT—Behcet's disease	3.48e-05	0.00112	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCR1—Behcet's disease	3.48e-05	0.00112	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—NOS3—Behcet's disease	3.42e-05	0.0011	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—Behcet's disease	3.4e-05	0.00109	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOB—Behcet's disease	3.38e-05	0.00108	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	3.29e-05	0.00105	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—APOB—Behcet's disease	3.26e-05	0.00104	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CTLA4—Behcet's disease	3.18e-05	0.00102	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCR1—Behcet's disease	3.15e-05	0.00101	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ICAM1—Behcet's disease	3.15e-05	0.00101	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.96e-05	0.00095	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.93e-05	0.000938	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CTLA4—Behcet's disease	2.88e-05	0.000923	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—NOS3—Behcet's disease	2.86e-05	0.000916	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ICAM1—Behcet's disease	2.85e-05	0.000915	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.78e-05	0.000892	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOA1—Behcet's disease	2.67e-05	0.000857	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	2.61e-05	0.000837	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.6e-05	0.000834	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—APOA1—Behcet's disease	2.58e-05	0.000826	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—Behcet's disease	2.35e-05	0.000753	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOB—Behcet's disease	2.34e-05	0.000752	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—Behcet's disease	2.31e-05	0.000742	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CAT—Behcet's disease	2.15e-05	0.000691	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—Behcet's disease	2.13e-05	0.000683	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOB—Behcet's disease	2.09e-05	0.00067	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	2.07e-05	0.000662	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—NOS3—Behcet's disease	2.03e-05	0.000649	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—Behcet's disease	1.95e-05	0.000624	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ICAM1—Behcet's disease	1.91e-05	0.000612	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOA1—Behcet's disease	1.85e-05	0.000595	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ICAM1—Behcet's disease	1.73e-05	0.000555	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CAT—Behcet's disease	1.7e-05	0.000544	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—SERPINE1—Behcet's disease	1.69e-05	0.000542	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOA1—Behcet's disease	1.65e-05	0.00053	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOB—Behcet's disease	1.65e-05	0.000528	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOB—Behcet's disease	1.64e-05	0.000526	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CAT—Behcet's disease	1.57e-05	0.000504	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOB—Behcet's disease	1.52e-05	0.000489	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CAT—Behcet's disease	1.51e-05	0.000484	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOB—Behcet's disease	1.49e-05	0.000477	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SERPINE1—Behcet's disease	1.47e-05	0.000472	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOB—Behcet's disease	1.46e-05	0.00047	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOS3—Behcet's disease	1.41e-05	0.000451	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOB—Behcet's disease	1.39e-05	0.000445	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOA1—Behcet's disease	1.3e-05	0.000418	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOA1—Behcet's disease	1.3e-05	0.000416	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—NOS3—Behcet's disease	1.25e-05	0.000402	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOA1—Behcet's disease	1.21e-05	0.000387	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CAT—Behcet's disease	1.2e-05	0.000384	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOA1—Behcet's disease	1.18e-05	0.000378	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOB—Behcet's disease	1.16e-05	0.000373	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOA1—Behcet's disease	1.16e-05	0.000372	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CAT—Behcet's disease	1.13e-05	0.000361	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOA1—Behcet's disease	1.1e-05	0.000352	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOB—Behcet's disease	1.09e-05	0.00035	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SERPINE1—Behcet's disease	1.03e-05	0.000331	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—NOS3—Behcet's disease	9.87e-06	0.000317	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOS3—Behcet's disease	9.84e-06	0.000316	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SERPINE1—Behcet's disease	9.35e-06	0.0003	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOA1—Behcet's disease	9.2e-06	0.000295	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NOS3—Behcet's disease	9.14e-06	0.000293	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOS3—Behcet's disease	8.92e-06	0.000286	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NOS3—Behcet's disease	8.78e-06	0.000282	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CXCL8—Behcet's disease	8.73e-06	0.00028	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SERPINE1—Behcet's disease	8.72e-06	0.00028	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOA1—Behcet's disease	8.64e-06	0.000277	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOS3—Behcet's disease	8.33e-06	0.000267	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CXCL8—Behcet's disease	7.92e-06	0.000254	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NOS3—Behcet's disease	6.97e-06	0.000224	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NOS3—Behcet's disease	6.55e-06	0.00021	CbGpPWpGaD
